SCHEMBL5834765

SCHEMBL5834765

CCN(CC)c1ccc(NC(=O)[C@]2(NC(=O)OCc3cccnc3)CCc3ccccc3C2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 5/20 0.69
NAMPT P43490 1/20 0.44
MAPT P10636 2/20 0.43
GFER P55789 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP3A4 P08684 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
GPR132 Q9UNW8 1/20 0.41
KCNH2 Q12809 1/20 0.39
POLB P06746 1/20 0.39
NOX1 Q9Y5S8 1/20 0.38
ROCK2 O75116 1/20 0.38
HDAC1 Q13547 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835222 1.00 GHSR (0.69) GHSRNAMPTMAPTGFERNPSR1
SCHEMBL5834854 0.90 GHSR (0.77) GHSRMAPTKMT2AMEN1ALDH1A1
SCHEMBL5834796 0.85 GHSR (0.82) GHSRMAPTGFERNPSR1CYP3A4
SCHEMBL5835377 0.83 GHSR (0.79) GHSRMAPTGFERKMT2AMEN1
SCHEMBL5835538 0.82 GHSR (0.77) GHSRMAPTGFERNPSR1KMT2A
SCHEMBL5835098 0.82 GHSR (0.77) GHSRMAPTGFERNPSR1KMT2A
SCHEMBL5835139 0.82 GHSR (1.00) GHSRMAPTGFERKMT2AMEN1
SCHEMBL5835307 0.82 GHSR (0.77) GHSRMAPTGFERCYP3A4KMT2A
SCHEMBL5836112 0.82 GHSR (0.77) GHSRMAPTGFERNPSR1KMT2A
SCHEMBL5835606 0.82 GHSR (0.77) GHSRMAPTGFERNPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885NAMPT 1730/4885MAPT 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.